Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, College of Medicine, Chungnam National University, Daejeon, Korea.
Department of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
Korean J Anesthesiol. 2024 Aug;77(4):423-431. doi: 10.4097/kja.23534. Epub 2024 Jul 30.
Noninferiority clinical trials are crucial for evaluating the effectiveness of new interventions compared to standard interventions. By establishing statistical and clinical comparability, these trials can be conducted to demonstrate that a new intervention is not significantly inferior to the standard intervention. However, selecting appropriate noninferiority margins and study designs are essential to ensuring valid and reliable results. Moreover, employing the Consolidated Standards of Reporting Trials (CONSORT) statement for reporting noninferiority clinical trials enhances the quality and transparency of research findings. This article addresses key considerations and challenges faced by investigators in planning, conducting, and interpreting the results of noninferiority clinical trials.
非劣效性临床试验对于评估新干预措施与标准干预措施的效果至关重要。通过建立统计学和临床可比性,这些试验可以进行,以证明新干预措施与标准干预措施没有显著差异。然而,选择适当的非劣效性边界和研究设计对于确保有效和可靠的结果至关重要。此外,采用 CONSORT 声明报告非劣效性临床试验可提高研究结果的质量和透明度。本文讨论了研究者在规划、进行和解释非劣效性临床试验结果时面临的关键考虑因素和挑战。